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Resveratrol, a polyphenol present in wine, has been thought to be
responsible for cardiovascular benefits associated with moderate wine
consuption. It is also present in the plant Polygonum Cuspidatum. The
mechanism of cardiovascular benefits probably includes vaso-
relaxation, antioxidant and anti-platelet effects of resveratrol. The
mechanisms by which resveratrol causes vasodilatation are uncertain.
The aim of this study was to investigate the mechanism(s) of resveratrol-
induced vasorelaxation in human internal mammary artery (HIMA) with
endothelium. HIMA rings were precontracted by phenylephrine.
Resveratrol induced relaxation of the HIMA rings with endothelium. L-
NAME, an inhibitor of NO synthase, and methylene blue, an inhibitor of
guanylate cyclase, abolished relaxation of HIMA, induced by
resveratrol. Highly selective blocker of ATP-sensitive K+ channels,
glibenclamide as well as a nonselective blocker of big Ca-sensitive K+
channels, charybdotoxin did not block resveratrol-induced relaxation of
HIMA. 4-Aminopyridine and margatoxin, blockers of voltage-gated K+
(KV) channels, abolished endothelium-dependent relaxation of HIMA,
induced by resveratrol. In conclusion, we have shown that resveratrol
induces relaxation of HIMA with endothelium. It seems that NO and
smooth muscle KV channels are included in this relaxation.
Key words: mammary artery, K+ channel, NO, resveratrol,
vasorelaxation
INTRODUCTION
Epidemiological studies have suggested that dietary factors, including
moderate wine consumption, might reduce the risk of cardiovascular diseases
(Diebolt et al., 2001). The lower incidence of coronary artery disease in Soutern
French and other Mediterranean populations, despite a diet rich in saturated fat
and high smoking habits (the so-called French paradox), has been attributed to
prolonged and moderate red wine consumption by these populations (Orallo et
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al., 2002). It is considered that resveratrol, as a polyphenol, is present in red wine
in significant amounts, and is partly responsible for the cardiovascular benefits
associated with wine consumption. The mechanism of cardiovascular benefits
probably includes vasorelaxation, antioxidant and anti-platelet effects of
resveratrol (Wu et al., 2001).
The mechanisms by which resveratrol causes vasodilatation are uncertain.
Today is known, that resveratrol-induced vasorelaxation may either be
endothelium-dependent (attenuated by L-NAME) or endothelium-independent
(Naderali et al., 2001). Resveratrol might become incorporated into the smooth
muscle membrane, where it could either couple with a membrane receptor or
interact directly with membrane ion channels, thus inducing endothelium
independent vasorelaxation (Jager and Nguyen-Duong, 1999; Andriambeloson
et al., 1999). Recently, it has been shown that some endothelial and peripherial
effects of resveratrol are mediated by activation of Ca2+ activated and voltage-
gated K+ (KV) channels (Wu, 2003, Granados-Soto et al., 2002).
HIMA is the vessel of choice for coronary artery bypass grafting (CABG).
Spasm of arterial graft conduit may occur during harvesting or immediately
following CABG (Rosenfeldt et al., 1999). The mechanism of graft spasm is not yet
elucidated although physical (mechanical manipulation, temperature changes),
and humoral factors (circulating vasoconstricting substances) have been evoked
(He et al., 1995). We have shown that potassium channel openers, pinacidil,
levcromakalim and rilmakalim, are potent antivasoconstrictors and vasodilatating
agents on the HIMA and that they can be considered as potential drugs in the
prevention of the bypass graft spasm (Gojkovic Bukarica et al., 1997, Novakovic et
al., 2003). Resveratrol is present in the plant Polygonum Cuspidatum. Its effects
on coronary bypass grafts have not been studied yet. Since some authors
(Andriambeloson et al., 1999; Chen et al., 1996; Naderali et al., 2000) have
studied the effects of resveratrol in animals, the authors performed the study on
human arteries, which are important both in cardiac and orthopedic surgery.
Therefore, the aim of this study was to investigate the effect of resveratrol on
HIMA, with endothelium, used as coronary bypass grafts, and to define the
contribution of different K+ channel subtypes in resveratrol action on this blood
vessel.
MATERIAL AND METHODS
The HIMA (n = 49) segments were collected from male patients (n = 49)
undergoing CABG suffering from coronary artery disease. Only arteries without
macroscopic evidence of atherosclerosis were used. All patients gave their formal
consent for excision of the remaining tissue. The experimental protocol was
approved by The Ethical Committee of Institute for cardiovascular diseases
"Dedinje". Research has been carried out in the accordance with Declaration of
Helsinki (2000) of the World Medical Association. The vessels were excised within
10 min of clamping the blood flow and placed in cold (4oC) Krebs-Ringer-
bicarbonate solution. After excision, the vessels were immediately transported to
the laboratory.
204 Acta Veterinaria (Beograd), Vol. 56. No. 2-3, 203-213, 2006.
Novakovi} Aleksandra et al.: Endothelium-dependent relaxation
of internal mammary artery produced by resveratrol
Assessment of vascular function
The HIMA segments were dissected free from connective tissue. They were
cut into rings (3 mm) and were mounted between two stainless-steel triangles in
an organ bath containing 10 ml Krebs-Ringer-bicarbonate solution (37oC, pH of
7.4), aerated with 95% O2 and 5% CO2. One of the triangles has been attached to a
displacement unit allowing fine adjustments of tension and the other was
connected to an isometric transducer (K30, Hugo Sachs, Freiburg, Germany).
The preparations were allowed to equilibrate for 30 min. During this period,
the vessels have been washed with a fresh buffer solution every 10 min. After the
equilibration period, the length-tension characteristics for each vessel were
determined as described previously (Gojkovic Bukarica et al., 1997). The resting
tension was 2 g (Schoeffter et al., 1988). Vascular rings were allowed a further 30
min to equilibrate before being contracted with phenylephrine.
Concentration-response curves were obtained by the cumulative addition of
resveratrol (1-100  M) to ring segments contracted to a stable plateau by adding
phenylephrine (10  M). Increasing concentrations of resveratrol have been added
only after the previous concentration had produced an equilibrium response or
after 20 min if no response was obtained. Therefore, the following protocol was
used: 1) contraction to phenylephrine and concentration-response curve to
resveratrol followed by three washes, addition of different K+-channel blockers
and a 20 min equilibration period; 2) contraction to phenylephrine and the
concentration-response curve to resveratrol.
We have examined the effects of resveratrol onto the rings with intact
endothelium. To assess the endothelial integrity of the preparation we have used
acetylcholine (20  M). Endothelium was considered to be intact when this drug
produced a strong vasorelaxation (>80%) of precontracted vascular rings. Failure
of arteries to relax to acetylcholine was considered to indicate a state of
endothelial denudation.
Data analysis
Relaxation produced by each concentration of resveratrol was measured
and expressed as a percentage of the maximum possible relaxation (i.e.,
relaxation back to the baseline tension). The concentration of resveratrol
producing 50% of the maximum response (EC50) was determined graphically for
each curve by linear interpolation.
The results are expressed as the means ± standard error of the mean
(SEM); n refers to the number of experiments. Statistical difference between
means was determined by Student’s t-test, and a P value <0.05 was considered
statistically significant.
Drugs
The following drugs were used: trans-resveratrol, phenylephrine,
acetylcholine, glibenclamide, charybdotoxin, 4-amynopiridine (4-AP), and
margatoxin (Sigma Chemical Co, St Louis, MO, USA). Resveratrol was dissolved
in 70% v/v ethanol with further dilution in distilled water before use. Working
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concentrations of ethanol in the bath were <0.01 % (v/v). Glibenclamide was
dissolved in polyethylene glycol. Previous experiments showed that the solvents
used had no effects on preparations at the concentrations applied. All drugs were
added directly to the bath in a volume of 50  L and the concentrations given were
the calculated final concentrations of the bath solution.
RESULTS
Effects of resveratrol on precontracted HIMA
Figure 1 shows the effect of resveratrol on the HIMA precontracted with
phenylephrine (10  M). Resveratrol (1-100  M) induced a concentration-
dependent relaxation of HIMA rings with endothelium (EC50 values of 34.7 ±
0.11  M, maximal response 86 ± 2 %, n = 49), (Fig. 1).
Effects of L-NAME and methylene blue on resveratrol-induced relaxation
L-NAME (100  M) and methylene blue (10  M) abolished resveratrol-
induced relaxation of HIMA (maximal responses: 83 ± 2 % in the absence vs. 2 ±
2 % in the presence of L-NAME, p<0.01, n = 7, and maximal responses: 83 ± 2 %
in the absence vs. 16 ± 2 % in the presence of methylene blue, p<0.011, n = 7,
respectively (Figure 2A and 2B).
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Figure 1. Concentration-response curve for resveratrol in the human internal mammary
artery. Rings were precontracted with phenylephrine (10  M). Responses are
expressed as a percentage of the maximum possible relaxation, i.e., the return of
tension to the pre-phenylephrine level. Each point represents the mean ± SEM
(n=49)
Effects of potassium channel antagonists on the resveratrol-induced
relaxation of HIMA with endothelium
Glibenclamide (10  M), charybdotoxin (10 nM), 4-AP (3 mM), and
margatoxin (10 nM) did not affect basal tension of HIMA (n=7, each; data not
shown).
Glibenclamide (10  M), a selective ATP-sensitive K+ (KATP) channels blocker
did not significantly modify the relaxation of HIMA induced by resveratrol (EC50 =
36.1 ± 0.14  M in the absence vs. 38.9 ± 0.11  M in the presence of
glibenclamide, P>0.05; maximal response 86 ± 2 % in the absence vs. 83 ± 5 %
in the presence of glibenclamide, P>0.05, n = 7) (Fig. 3A).
Charybdotoxin (10 nM), an inhibitor of big Ca-sensitive K+ (BKCa) channels
as well as KV channels did not affect the relaxation of HIMA produced by
resveratrol (EC50 = 38.5 ± 0.17  M in the absence vs. 43.1 ± 0.12  M in the
presence of charybdotoxin, P>0.05; maximal response 88 ± 2 % in the absence
vs. 83 ± 2 % in the presence of charybdotoxin, P>0.05, n = 7) (Fig. 3B).
4-AP (3 mM), predominant blocker of KV channels abolished resveratrol-
induced relaxation of HIMA (maximal response: 89 ± 2 % in the absence vs. 4 ±
2% in the presence of 4-AP, P<0.01, n = 7) (Fig. 3C).
Margatoxin (10 nM), potent inhibitor of KV1.1, KV1.2, KV1.3, and KV1.6
channels abolished the resveratrol-induced relaxation of the HIMA (maximal
responses: 83 ± 2 % in the absence vs. 4 ± 2 % in the presence of margatoxin,
p<0.01, n = 7) (Fig. 3D).
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Figure 2. Antagonism of the relaxant effect of resveratrol by a L-NAME and methylene blue
in the human internal mammary artery. Concentration-response curves for
resveratrol in the absence and presence of L-NAME (A) and methylene blue (B).
Responses are expressed as a percentage of the maximum possible relaxation, i.e.,
the return of tension to the pre-phenylephrine level. Each point represents the mean
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DISCUSSION
Several studies suggested vasorelaxant effects of polyphenolic compounds
(Andriambeloson et al., 1997; Fitzpatrick et al., 1995). Resveratrol is thought to be
a prime compound of the polyphenols, causing relaxation of the rat aorta,
mesenteric and uterine artery of guinea pig, prior contracted by phenylephrine,
noradrenaline or KCl (Chen and Pace-Asciak, 1996; Naderali et al., 2000; Orallo et
al., 2001; Naderali et al., 2001). In the present study, we have shown that
resveratrol induces concentration-dependent relaxation of HIMA with
endothelium.
208 Acta Veterinaria (Beograd), Vol. 56. No. 2-3, 203-213, 2006.
Novakovi} Aleksandra et al.: Endothelium-dependent relaxation
of internal mammary artery produced by resveratrol
Figure 3. Antagonism of the relaxant effect of resveratrol by a K+ channel inhibitors in the
human internal mammary artery. Concentration-response curves for resveratrol in
the absence and presence of: glibenclamide (A), charybdotoxin (B), 4-amynopiridine
(C) and margatoxin (D). Arteries were contracted with phenylephrine (10  M).
Responses are expressed as a percentage of the maximum possible relaxation, i.e.,
the return of tension to the pre-phenylephrine level. Each point represents the mean
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Today it is known that the endothelium-dependent effect of resveratrol is
apparent at low concentrations (10-30  M) and is blocked by inhibitors of NO
synthase. In our study, pretreatment with L-NAME, an inhibitor NO synthesis,
completely abolished endothelium-dependent relaxation of HIMA rings produced
by resveratrol. This finding is in agreement with previous reports where
resveratrol-induced vasodilatation was attenuated by inhibitors of NO synthesis
(Chen and Pace-Asciak, 1996; Fitzpatrick et al., 1995; Naderali et al., 2001). In
addition, the relaxation induced by resveratrol was blocked by methylene blue, an
inhibitor of soluble guanylate cyclase (Kuriyama et al., 1995, Moncada et al.,
1997). These results correspond to those reported in the rat aorta by Orallo et al.
(2002). According to this, it seems that endothelium-dependent vasorelaxation of
HIMA caused by resveratrol could be mediated by endothelial generation and
release of NO. Indeed, NO is the predominant endothelium derived dilator of the
HIMA and synthesized after stimulation with vasoconstrictor phenylephrine
(Archer et al., 2003). The mechanism underlying the NO-induced vasodilatation
has been intensively investigated. Current knowledge suggests a central role for
cGMP-dependent activation PKGI which can phosphorylate different membrane
proteins. NO can also activate KCa channels and increase the outward potassium
current. It has been shown that this action of NO can be both independent and
dependent on activation PKGI (Gewalting and Kojda, 2002). Finally, cGMP-
dependent inhibition of voltage-gated Ca-channels might also be involved in the
mechanism of vasodilatation induced by NO. The relative contribution of each of
these PKGI and K+ channels dependent vasodilating mechanisms of NO remains
to be determined (Gewalting and Kojda, 2002).
To determine whether the K+ channels mediated relaxation of HIMA with
endothelium induced by resveratrol, we used different potassium channel
blockers.
To analyze the contribution of KATP channels to the endothelium-dependent
resveratrol-induced relaxation of the HIMA, we used glibenclamide (10  M).
Glibenclamide is known as one of the most selective blockers of KATP channels,
although when used in a high concentration (>30  M), it may block some other
types of K+ channels (Sturgess et al., 1985, Schmid-Antomarchi et al., 1987, Cook
and Quast, 1990). In the present study, glibenclamide did not inhibit the relaxation
of HIMA induced by resveratrol. Accordingly, it seems that KATP channels are not
involved in the pathway by which resveratrol produces a relaxation of the HIMA.
This result is in agreement with the view that glibenclamide does not antagonize
antinociceptive effect of resveratrol (Granados-Soto et al., 2002).
To analyze the possibility that the endothelium-dependent relaxation of the
HIMA, evoked by resveratrol, is mediated via BKCa channels, charybdotoxin was
tested. It has been shown that charybdotoxin blocks BKCa channels in the
vascular smooth muscle (Cook and Quast, 1990). However, charybdotoxin is not
a specific blocker of BKCa channels, it also inhibits intermediate conductance
Ca2+-activated K+ channels and KV channels (1.2 and 1.3 channels) (Feld et al.,
2002; Suarez-Kurtz et al., 1999). In each case, channel inhibition occurs with
similar potency in the low nanomolar range (Kd ¬ 0.3 and 10 nM) (Wallner et al.,
1999). The concentration of charybdotoxin used in our study was sufficient to
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block BKCa channels, but did not alter relaxation of the HIMA induced by
resveratrol. Accordingly, it seems that charybdotoxin-sensitive channels are not
involved in the mechanism of resveratrol-induced relaxation of the HIMA. This
finding is in contrast to the finding of Wu et al. (2003) who demonstrated that
resveratrol opens BKCa channels in the vascular endothelial cell.
To analyze the contribution of KV channels to the resveratrol-induced
relaxation in the HIMA, we used 4-AP. This compound is the most widely used
blocker in the identification of potassium channel types. With very few exceptions,
4-AP have been shown to be without effect on BKCa (Ritchie, 1987). Using low
millimolar concentration, 4-AP achieved some selectivity for KV channels (Beech
and Bolton, 1989). This feature complies with the results given by our experiments
i.e. 4-AP (3 mM) antagonized resveratrol-induced relaxation of HIMA rings with
comparable potency. Thus, our finding supports a relevant participation of KV
channels in the relaxation of HIMA produced by resveratrol. Consistent with this
idea is the result obtained by Granados-Soto et al. (2002) that suggested that
activation of KV channels participated in the peripheral nociceptive effect of
resveratrol.
We used margatoxin in order to test which subtype of KV channels was
included in resveratrol-induced relaxation of HIMA. This peptide is highly selective
inhibitor of the KV1 channels, especially 1.1, 1.2, 1.3, and 1.6 subtypes, but
displays no affinity for the mammalian BKCa channel (Garcia-Calvo et al., 1993,
Cheong et al., 2001). KV1.2 and KV1.3 were identified in vascular smooth muscle
cell of rat mesenteric artery; KV1.1 and KV1.6 were detected in smooth muscle cell
of rat aorta and rat pulmonary artery but not in smooth muscle cell of mesenteric
artery (Xu et al., 1999; Archer et al., 1998). This reflects tissue differences in
expression of KV1 channels subtypes. In our study, th applied margatoxin (10 nM)
was sufficient to block KV1.1, KV1.2, KV1.3, and KV1.6 channels, by abolishing
resveratrol-induced relaxation, suggests that those channels might be included in
the mechanism of resveratrol-induced endothelium-dependent vasodilatation of
HIMA (Garcia-Calvo et al., 1993, Cheong et al., 2001). However, the fact that
charybdotoxin, a potent blocker of KV1.2 and KV1.3 did not reproduce the effect of
margatoxin suggests that KV1.1 and/or KV1.6 may be the relevant target. This
observation needs further evaluation.
In conclusion, we have shown that resveratrol can induce relaxation of HIMA
with endothelium. It seems that NO and 4-AP- and margatoxin-sensitive voltage-
gated K+ channels located in the smooth muscle of HIMA are included in this
relaxation. Further investigations have been necessary to explain the nature of
interaction between NO and K+ channels in HIMA.
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ENDOTEL-ZAVISNA RELAKSACIJA UNUTRA[NJE TORAKALNE ARTERIJE
PROUZROKOVANA REZVERATROLOM
NOVAKOVI] ALEKSANDRA, GOJKOVI]-BUKARICA LJILJANA, PERI] M, NE@I] D,
DJUKANOVI] B, LE[I] A, BUMBA[IREVI] M i MARKOVI]-LIPKOVSKI JASMINA
SADR@AJ
Smatra se da rezveratrol kao jedna polifenolna komponenta prisutna u
zna~ajnim koli~inama u crnom vinu, smanjuje rizik od razvoja ateroskleroze i
koronarne bolesti. U mehanizam kardioprotektivnog delovanja verovatno su uk-
lju~eni antioksidativno, antitrombocitno i vazodilatatorno delovanje rezveratrola.
Mehanizam vazodilatacije jo{ uvek nije poznat, pa je cilj ovog rada bio da se ispi-
taju efekti i mehanizam vazorelaksantnog delovanja rezveratrola na humanoj unu-
tra{njoj torakalnoj arteriji sa endotelom. Unutra{nja torakalna arterija je prekontra-
hovana fenilefrinom. Rezveratrol je koncentracijski-zavisno relaksirao unutra{nju
torakalnu arteriju ~oveka. L-NAME, inhibitor NO sintaze, i metilensko plavo, inhibi-
tor solubilne gvanilat ciklaze, su antagonizovali relaksaciju unutra{nje torakalne
212 Acta Veterinaria (Beograd), Vol. 56. No. 2-3, 203-213, 2006.
Novakovi} Aleksandra et al.: Endothelium-dependent relaxation
of internal mammary artery produced by resveratrol
arterije sa intaktnim endotelom, prouzrokovanu rezveratrolom. Visoko selektivni
blokator ATP-senzitivnih K+ kanala, glibenklamid, kao i neselektivni blokator ve-
likih Ca-senzitivnih K+ kanala, karibdotoksin nisu antagonizovali rezveratrolom in-
dukovanu relaksaciju unutra{nje torakalne arterije. 4-Aminopiridin i margatoksin,
blokatori volta`nih K+ kanala su antagonizovali relaksaciju prouzrokovanu rez-
veratrolom.
Na osnovu ovih ~injenica se mo`e zaklju~iti da je endotel-zavisna relaksa-
cija unutra{nje torakalne arterije ~oveka, prouzrokovana rezveratrolom, verovatno
posredovana NO. Izgleda, da su 4-aminopiriin- i margatoksin-senzitivni K-kanali
sme{teni u membrani vaskularnih glatko-mi{i}nih }elija humane unutra{nje to-
rakalne arterije, uklju~eni u mehanizam endotel-zavisne relaksacije prouzroko-
vane rezveratrolom.
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